The hypothesis that serotonin (5-HT) and dopamine stimulate prolactin (PRL) release, either directly from the pituitary gland or by acting through Vasoactive Intestinal Peptide (VIP), was investigated by assessing the role of hypothalamic dopamine and 5-HT in the control of broodiness and PRL release in Cantonese native chicken breed called the Yuehuang hen. A second objective was to assess the involvement of hypothalamic VIP in the control of broodiness and PRL release by using dopamine and serotonin receptor antagonists respectively. In Experiment 1, two hundred laying hens from battery cages were transferred to floor pens with nest boxes to induce broodiness. Starting from the second day after the onset of broodiness, sixty hens were allotted into groups 1, 2 and 3 respectively, corresponding to chlorpromazine-treated (n = 20), cyproheptadine-treated (n = 20) and control (n = 20) groups. Blood samples were collected from the wing veins of hens in each group on days 2, 5, 9, 14 and 19 respectively after the onset of broodiness for radioimmunoassay of PRL and Luteinizing Hormone (LH). Results indicate that in the drug treated hens which terminated broodiness, the concentration of plasma PRL decreased significantly (p<0.01) while the concentration of plasma LH increased significantly (p<0.05) as compared to the control hens. The plasma PRL levels showed no significant (p>0.05) changes between the chlorpromazine and cyproheptadine treated hens. Within the chlorpromazine and cyproheptadine treated hens, there were significant (p<0.05) changes in plasma PRL levels between day 2 and days 5, 9, 14 and 19. The plasma PRL levels in the control hens showed no significant (p>0.05) changes throughout the blood sampling periods. Sixteen (80%) chlorpromazine treated hens terminated broodiness on an average of 4.6±0.8 days but four hens (20%) did not. However, thirteen (65%) cyproheptadine treated hens terminated broodiness on an average of 2.3±0.2 days while seven (35%) did not. In Experiment 2, sixty animals were used but their management and drug treatment for group 1 (n = 10) and group 2 (n = 10) were the same as described in Experiment 1. Group 3 (n = 10) served as the control. Eight hens each from groups 1, 2 and 3 were randomly selected for immunohistochemical studies. On day 7 after the onset of broodiness, hypothalamus from anaesthetized chlorpromazine and cyproheptadine treated hens as well as control hens were processed for immunohistochemical localization of VIP neurons in the hypothalamus of Yuehuang hens. Morphological observation showed a higher number of VIP neurons in the hypothalamus of the control hens. A few VIP neurons which were very faint were also found in the hypothalamus of the chlorpromazine and cyproheptadine treated hens. Results of these studies indicate a relationship between the functions of dopamine and 5-HT neurons in the hypothalamus and reproductive activities in domestic hens. They are consistent with the view that hypothalamic dopamine and 5-HT are regulators of PRL release and that using drugs which inhibit the functional activities of these neurotransmitters can inhibit PRL release to disrupt broodiness in hens to maintain egg production. The results also indicate a causal relationship between hypothalamic VIP and changes in PRL secretion associated with reproductive activities in domestic hens. This is consistent with the view that VIP might be an important hypothalamic PRL releasing neuropeptide and also indicate that VIP might be a physiological PRL regulatory hormone in domestic hens.
INTRODUCTION
Broodiness describes the inherent behaviour displayed most frequently by domestic hens after they have laid a clutch of eggs which would be incubated under feral conditions. The development of broodiness is induced by interactions between the environment, genotype and the endocrine system (Sharp, 1989) . Convincing of changes in circulating PRL associated with evidence (El Halawani et al., 1991a,b; reproductive cycle. The low LH level found was attributed 1991) have been presented implicating increased PRL to minimal hypothalamic induction of LH release during secretion as a cause of reduced circulating the various stages of the reproductive cycle. The gonadotropins, ovarian regression and the shift from hypothesis that during incubation, female turkeys exhibit egg laying to the broody phase of reproduction.
elevated circulating PRL which may be the result of The main functions of the endocrine system that lead to enhanced pituitary responsiveness to VIP induces an the development of broodiness are an increase in the increase in LH secretion in all reproductive groups concentration of plasma PRL (Sharp et al., 1988; Etches (Sharp et al., 2005) . This shows that VIP enhances and Cheng, 1982) and as egg laying stops, a fall in Luteinizing Hormone Releasing Hormone (LHRH) plasma LH and ovarian steroids. The increase i n induced LH secretion. This shows that PRL secretion in plasma PRL plays a role in the initiation and vitro by pituitary cells from turkeys in various reproductive maintenance of broody behaviour (Janik and Buntin, stages reflected the circulating levels of PRL at these 1985) and in the suppression of gonadotropin release stages. PRL release in turkeys may be modulated by (Lea et al., 1981) .
gonadal steroids acting directly on the cells of anterior The onset and maintenance of broody behaviour i s pituitary (Knapp et al., 1988) . Therefore, these steroids dependent upon the nest entry induced progesterone probably enhance the response of the lactotrophs to surges in laying hens (El Halawani et al., 1991a,b) . This neuropetide induction of PRL release by increasing PRL indicates that nest entry and persistent nesting are synthesis and storage. Immuno-neutralization of VIP can prerequisite for the PRL induction of broody behaviour inhibit PRL release so as to inhibit the development of which triggers the elevated PRL levels which maintain broodiness and maintain egg laying in birds. Daily broody activity. Tactile stimulation from the brood patch injection of cVIP antibody led to broody hens deserting which is provided by the eggs or floor of the nest site their nests within 3-5 days (Sharp et al., 1989) . This stimulates PRL secretion since the removal of a broody shows that the VIP antibodies in the peripheral hen from its nest results in rapid decrease in plasma circulation were able to immuno-neutralize VIP effectively PRL (Sharp et al., 1988) . This observation indicates that in the hypophysial vasculature. Active immunization of once broodiness is initiated, it is maintained only by high turkeys against VIP (El Halawani et al., 1995) starting on levels of plasma PRL. This is supported by the fact that the day of photo-stimulation with cVIP conjugated to injection of ovine PRL to broody bantam hens deprived keyhole limpet haemocyanin depressed PRL release of their nests maintained readiness to incubate (Sharp compared to the controls. Chen et al. (1997 Chen et al. ( ) actively et al., 1988 . PRL secretion in birds is predominantly immunized Taihe hens with the conjugate of c-terminal regulated by releasing factors of which the best fragment of VIP and Bovine Serum Albumen (BSA) to characterized are VIP, 5-HT and dopamine (Hall et al., study the effect on their reproductive performance. The 1986).
results indicate that active immunization against VIP The most important neuroendocrine influence on PRL decreased plasma PRL and broody rate, and secretion in birds may be attributed to VIP which is consequently maintained egg production. secreted from the hypothalamus. VIP is produced by
The n eural mechanisms that govern increased PRL neurons in the medial basal hypothalamus and external secretion in broody hens appear to involve median eminence. It is then transported in the portal monoaminergic systems and that both hypothalamic 5-vascular system to the pituitary gland, where i t HT and dopamine have been implicated (El Halawani stimulates the secretion of PRL from the lactotrophic and Rozenboim, 1993). Serotonin (5-HT) facilitates the cells (Etches, 1996) . The regulatory mechanisms for release of pituitary PRL in turkey hens when they are increased PRL secretion in broody hens appear t o treated with methysergide, a 5-HT receptor blocker, and involve modulation at the level of both the hypothalamus prevents the increase in PRL in response to electrical and pituitary. The medial basal hypothalamus contains stimulation of the hypothalamus (El Halawani et al., the final neural elements that regulate anterior pituitary 1988b). This substantiates the proposition that 5-HT is secretion of PRL in the turkey (El Halawani and a central neurotransmitter that stimulates PRL secretion Rozenboim, 1993) . (Hall et al., 1986) . Serotonin is also involved i n Hypothalamic VIP increases PRL secretion from mediating a nesting stimulated increase in PRL chickens and turkey pituitary glands particularly when the secretion and maintenance of broody behaviour. PRL is pituitary gland responsiveness is enhanced with secreted by the administration of serotonin or drugs estrogen pre-treatment (Sharp et al., 2005) . The role of which mimic its action in the brain (Macnamee and the anterior pituitary gland in the expression of changes Sharp, 1989a) . There is also an increase in the turnover in the circulating PRL and LH levels associated with the of serotonin in the hypothalamus of broody turkey hens reproductive cycle of turkeys was investigated by El (El Halawani and Burke, 1976) while systemic o r Halawani et al. (1988a) . It was found that the anterior cerebro-ventricular injection of serotonin, serotonin pituitary of turkeys appear to have a role in the induction precursor, or serotonin agonist, stimulate PRL release (Hargis and Burke, 1984) . The administration o f the control group and on day 7 for the groups 1 and 2 serotonin synthesis inhibitor, p-chlorophenylalanine hens which terminated broodiness within 2 to 5 days (PCPA) inhibits PRL release in re-nesting and broody following drug treatment, 8 hens in each group were turkeys (El Halawani et al., 1983) .
killed for immunohistochemical localization of VIP in the The stimulatory role of dopamine in the regulation of hypothalamus. The hens were anaesthetized by intra-PRL release was investigated by the administration of muscular (i.m) injection of 0.5 mg ketamine and jugular low doses of dopamine directly into the brain of broody arteries were exposed. Forty (40) ml 0.1M PBS (pH 7.3) turkey hens (Macnamee and Sharp, 1989b) . This was infused into the arteries followed by 80 m l resulted in increased turnover of hypothalamic phosphate buffered 4% formaldehyde (pH 7.3) which dopamine. The turnover of dopamine increased in the served as a fixative. Hypothalamus was dissected out hypothalamus of turkeys during the transition from laying and fixed in the above mentioned fixative for to incubation (El Halawani and Burke, 1976) .
immunohistochemical detection of VIP neurons. The present study was undertaken to: (1) investigate the role of hypothalamic dopamine and serotonin (5-HT) in
Hormone assays the control of broodiness and PRL release in the Radioimmunoassay of LH: To 5 µl of USDA-cLH-1-3 (LH Yuehuang hen and (2) assess the involvement o f tracer) in plastic iodination vial was added 20 µl of 0.25 hypothalamic VIP in the control of broodiness and PRL mol/L phosphate buffer to dissolve the content. This was release by using dopamine and 5-HT receptor followed by the addition of 0.5 mCi of high specific antagonists.
activity Na I. After that, 10 µl of 0.25 mol/L phosphate
MATERIALS AND METHODS
Animals, management and sampling Experiment 1: Two hundred laying Yuehuang hens, fifty weeks old and about 2.0 kg live weight, from the South China Agricultural University Experimental Poultry Farm and housed in battery cages were randomly selected and transferred to floor pens (2.5 m x 2.0 m) containing nest boxes to induce broodiness. The birds were kept in groups of five. All eggs laid by the hens were removed daily. The hens were exposed to natural lighting conditions and they had free access to water and feed. Hens which expressed signs of broodiness were taken for t he experiment. Broodiness was recognized a s persistent nesting combined with characteristic clucking. Starting from the second day after the onset o f broodiness, each hen in group 1 (n = 20) was orally treated with 150 mg chlorpromazine (dopamine receptor antagonist) per day until the termination of broodiness. Each hen in group 2 (n = 20) was orally treated with 20 mg cyproheptadine (5-HT receptor antagonist) per day until the termination of broodiness and hens in group 3 (n = 20) served as the control. However, drug treatment continued for the hens which did not terminate broodiness until day 7 and it was stopped. Blood samples were collected from the wing veins of hens in groups 1 to 3 on days 2, 5, 9, 14 and 19 respectively after the onset of broodiness. The blood samples were centrifuged and stored at -20°C until assayed for PRL and LH.
Experiment 2: Sixty Yuehuang hens, fifty weeks old and about 2 kg live weight, from the South China Agricultural University Experimental Poultry Farm and housed in battery cages were randomly selected and used for the experiment but their management and drug treatment for group 1 (n = 10) and group 2 (n = 10) were the same as described in experiment 1. Group 3 served as the control (n = 10). On days 2 and 7 after the start of broodiness for 123 buffer containing chloramine T (58 mg/ml) was added to initiate the iodination reaction. The reaction was allowed to proceed for 5 min and finally ended by the addition of 100 µl of transfer solution (composed of 1% KI, 16% sucrose and 0.01% bromophenol blue). This was followed by the addition of 200 µl of 10% Bovine Serum Albumin (BSA) to the iodination vial. The iodination reaction mixture was then removed and loaded onto a Sephadex G-25 column, eluted with 0.05 mol/L phosphate buffer (pH 7.4). Eight-drop fractions were collected in eight test tubes until the dye was completely eluted from the column. The fraction containing the first peak of radioactivity was used as tracer for the radioimmunoassay. The assay buffer was 0.05 M Phosphate Buffered Saline (PBS) solution (pH 7.4) enriched with 0.1% BSA. Duplicate plasma samples and aliquots of standard (USDA-cLH-K-3) comprising 16, 8, 4, 2, 1, 0, 5, 0.25, 0.125, 0 .061 and 0.03 ng/ml were dissolved in assay buffer with 2% (v/v) broody hens plasma. To each of the tubes was added 100 µl assay buffer plus another 400 µl PBS to make a volume of 0.5 ml. After that, 200 µl of 0.05M PBS containing 0.05M EDTA and 0.5% normal rabbit serum (first antibody) at a dilution of 1:12500 was added to each of the standard and the sample tubes except non-specific binding. This was followed by the addition of 100 µl of I-LH (labelled 125 LH) in assay buffer and the mixture incubated at 4°C for 48 h. After that, 100 µl of donkey anti-rabbit antiserum (second antibody, purchased from the Northern Institute of Immunology, Beijing) at 1:20 dilution in PBS was added to each tube except Total. The tubes were incubated at 4°C for 24 h. This was followed by the addition of 2.0 ml of spinning down buffer (0.05M PBS plus 6% polyethylene glycol of molecular weight 6000) to all tubes except Total and centrifuged at 1900 g for 30 min in a refrigerated centrifuge at 4°C. The supernatants were discarded and the radioactivity in the precipitates counted in a gamma counter to determine the L H concentration in each sample.
Radioimmunoassay of PRL:
The method for radioiodination and the procedure for radioimmunoassay were the same as in radioimmunoassay of LH above except that the reference standard and the concentrations of the first and second antibodies were different. The chicken PRL tracer used for radioiodination was AFP-4444B. Duplicate serum samples and aliquots of standard (AFP-10328B) comprising 50, 25, 12.5, 6.25, 3.13, 1.56, 0.78, 0.39 and 0.19 ng/tube was used. Two percent (2%) normal rabbit serum (AFP-151040789) in 0.1 mol/L PBS (pH 7.4) at 1:50000 dilution was used as the first antibody while donkey antirabbit antiserum at 1:4 dilution was used as the second antibody.
Immunohistochemical localization of VIP in the hypothalamus: Following fixation of the hypothalamus in phosphate buffered 4% formaldehyde (pH 7.3) for 24 h, the t issue blocks were dehydrated in solutions o f alcohol of increasing concentration. Xylene was used as inter-medium before the tissues were embedded in hot paraffin. The tissues were sectioned transversely (15 µm) on a tissue slicing microtome and processed for immunohistochemical localization of VIP using Peroxidise-Antiperoxidase Procedure (PAP). The primary antibody, sheep anti-VIP (6DL31/4) was used at a dilution of 1:4000. Rabbit anti-goat antibody (2454, Dako) at a dilution of 1:150 was used as a link. Then, goat-PAP (130157 Dako) at a dilution of 1:100 was used before the addition of Diaminobenzidine (DAB) to induce colour formation.
Statistical analysis:
Hormone values were analyzed by using analysis of variance and General Linear Model procedures in the Statistical Analysis System (SAS, 1999) for treatments and time effects as well a s interactions between the variables. Differences between means of significant effects were separated by the probability of differences procedure of SAS (1999).
RESULTS

Experiment 1: Effects of chlorpromazine o r cyproheptadine on broodiness and plasma PRL and LH concentrations Changes in broody behaviour:
The control hens continued to nest throughout the period when they were broody. Out of twenty chlorpromazine treated hens, sixteen (80%) terminated broodiness on 4.6±0.8 days after start of treatment, while four (20%) continued to be broody even after 7 days of treatment. Again, out of twenty cyproheptadine treated hens, thirteen (65%) terminated broodiness on 2.3±0.2 days, while seven (35%) continued to be broody and showed persistent nesting after 7 days of treatment.
Changes in plasma PRL levels:
The treatment o f Yuehuang hens with 5-HT receptor antagonist (cyproheptadine) and dopamine receptor antagonist (chlorpromazine) significantly (p<0.5) depressed the release of PRL and disrupted broodiness (Table 1 ). In the c ontrol hens, there were no significant (p>0.5) changes in plasma PRL levels throughout the blood sampling period. The plasma PRL levels were maintained between 200 and about 400 ng/ml. There were no significant (p>0.05) differences in plasma PRL levels between the three groups before the drug treatment started for groups 1 and 2. Following drug treatment, the hens which terminated broodiness had plasma PRL levels significantly (p<0.01) lower than those in the control group (Table 1) .
Changes in plasma LH levels:
For the hens which terminated broodiness by treatment with chlorpromazine or cyproheptadine, plasma LH levels significantly (p<0.01) increased from below 1 ng/ml before drug treatment to almost 3 ng/ml, on day 19 following onset of broodiness, whereas the levels in control hens was maintained below 1 ng/ml throughout the sampling period (Table 2 ). Table 2 : Plasma LH concentrations (ng/mL) of control hens (group 3, n = 7), chlopromazine treated (group 1, n = 7) and cyproheptadine treated (group 2, n = 6) which also terminated broodiness following drug treatment Days of 2 5 9 14 19 broodiness - Plate 1: Non-treated control hens killed on day 2 after onset of broodiness (x100)
-----------------------------------------Plasma prolactin concentrations (ng/mL) (Mean±SEM) -------------------------------------------
-------------------------------------------Plasma LH concentrations (ng/mL) (Mean±SEM) ---------------------------------------------
Plate 2: Non-treated control hens killed on day 7 after onset of broodiness (x100)
Plate 3: Cyproheptadine treated hens which terminated broodiness and were killed on day 7 (x100) Experiment 2: Observations on VIP neurons in the hypothalamus: A higher number of positive VIP neurons were found in the hypothalamus of the control hens on days 2 and 7 of broodiness. The neurons were strongly stained and also some areas outside the neurons were stained as well (Plates 1 and 2). For hens which terminated broodiness by either chlopromazine or cyproheptadine treatment, VIP positive neurons were not strongly stained nor was there a strong VIP positive background in the vicinity of the neurons (Plates 3
Plate 4: Chlopromazine-treated hen which terminated broodiness and were killed on day 7 (x100) and 4). These results indicate that in broody hens, there is a higher production of VIP by the hypothalamus than in hens in which drugs are used to terminate broodiness.
DISCUSSION
The dopamine receptor antagonist, chlopromazine and serotonin (5-HT) receptor antagonist, cyproheptadine, were very effective in blocking the onset of broodiness when they were given at the right time. The hens were treated starting from the second day after the onset of broodiness so the drugs were very effective in interfering with the functional activities of neurons containing dopamine and 5-HT to block them from stimulating VIP to release PRL. As a result, the plasma PRL levels were depressed so broodiness was disrupted and the hens deserted their nests. In broody turkey hens, dopaminergic inhibition diminishes and allows for increased PRL release (El Halawani et al., 1991a,b) . However, when chlopromazine was administered to the broody hens, it was very effective in blocking the functional activity of dopamine in the hypothalamus to inhibit PRL release. This may be the reason why broodiness was terminated in eighty percent (80%) of the treated hens. Dopamine inhibits PRL release from chicken and turkey anterior pituitary cells in vitro (Harvey et al., 1982) . This indicates that the stimulatory effect of dopamine occurs in the hypothalamus. Increased dopaminergic activity could stimulate PRL synthesis and release which in turn have an anti-gonadal effect by blocking gonadotropin stimulation (Millam et al., 1980) to cause broodiness in birds. Therefore, the use of dopamine receptor antagonist inhibits the stimulatory effect of increased dopaminergic activities to block PRL release. This in turn disrupts broodiness to maintain egg laying. There is a transitory increase in the metabolism of dopamine in the brain of turkey hens during transition from laying to the broody phase of the reproductive cycle (El Halawani and Burke, 1976) . This increase corresponds with the period when plasma PRL is increasing and plasma LH is decreasing (Burke and absorption. Disruption of nesting is associated with drug Dennison, 1980). These observations indicate that treatment designed to disrupt broodiness. A broody hen dopamine regulates PRL release in birds and plays a which spends a lot of time on the nest is restricted from causal role in broodiness. It is therefore possible to use feeding and persistent nesting itself induces dopamine receptor antagonist, chlopromazine, to inhibit broodiness. Therefore, treating broody hens with the regulatory effect of dopamine to block PRL release chlopromazine and cyproheptadine starting from the and to disrupt broodiness in domestic hens.
second day after the onset of broodiness tends to thwart Cyproheptadine, the 5-HT receptor antagonist, might the hens desire to nest so as to keep them have entered the hypothalamus to inhibit the functional reproductively active. activity of 5-HT to block the PRL-releasing effect of 5-HT.
The observations of different numbers of VIP neurons in As a result, sixty five percent (65%) of the drug treated the hypothalamus of the control hens and the drug hens terminated broodiness. Serotonin (5-HT) treated hens which terminated broodiness and were stimulates PRL release in avian species (Hall et al., killed on day 7 after the onset of broodiness correspond 1986). However, the failure of 5-HT to induce PRL to the different levels of circulating PRL in the birds release in vitro (Proudman and Opel, 1981; during the different periods. The relationship between 1985) and also the absence of 5-HT receptors in the changes in the VIP contents and alterations in PRL in anterior pituitary of bantam hens (Macnamee and Sharp, the birds during the different stages in the reproductive 1989a) indicate that the excitatory effects of 5-HT on PRL cycle indicates that fluctuations in hypothalamic VIP play release may occur within the hypothalamus. This a major role in the regulation of PRL secretion. This demonstrates that the functional integrity of serotonergic shows that VIP is a potent PRL-releasing neuropeptide neurons is involved in the mechanism of PRL release in in domestic hens. In the drug treated hens which the hypothalamus. It is therefore possible that terminated broodiness and were killed on day 7, it could cyproheptadine might have blocked the functional activity be said that PRL release was probably depressed for of serotonergic neurons in the hypothalamus to inhibit about 7 days when the drugs were present in the the stimulation of VIP to release PRL so as to terminate peripheral circulation. This observation shows that VIP broodiness in sixty five percent (65%) of the treated may be the only PRL-releasing factor maintaining high hens. This substantiates the proposition that 5-HT is a levels of plasma PRL. central neurotransmitter that stimulates PRL secretion
The absence of VIP neurons in the hypothalamus of the (Hall et al., 1986) . The disruption of broody behaviour in chlopromazine and cyproheptadine treated hens which the hens by oral administration of dopamine and 5-HT terminated broodiness and were killed on day 15 after receptor antagonists is consistent with the view that an onset of broodiness shows that there was marked increased concentration of plasma PRL maintains decline in the number of VIP neurons in the broody behaviour (Janik and Buntin, 1985; hypothalamus and this was associated with a significant 1988). Therefore, in the presence of all environmental depression in circulating PRL. This is consistent with stimuli necessary for the maintenance of broody the hypothesis that changes in plasma PRL levels in behaviour, the depression of plasma PRL after the broody hens are associated with changes i n administration of the drugs to inhibit the functional hypothalamic VIP. Therefore, reduced levels of PRL in activities of dopamine and 5-HT was associated with the the drug treated broody hens were associated with disruption of broodiness. This demonstrates that 5-HT reduction of VIP in the hypothalamus. These results and dopamine may be potential PRL regulators i n indicate that chlopromazine and cyproheptadine can domestic hens. Again, it indicates that the hypothalamic inhibit PRL release and the effect is through inhibition of control of PRL secretion in birds is primarily under VIP in the hypothalamus. stimulatory control, in contrast to the inhibitory control exerted by dopamine in mammals (Hall et al., 1986) .
Conclusion:
The reproductive efficiency of domestic The neural mechanisms involved may have been fully hens can be improved by the use of chlopromazine and activated in the broody hens since in all species studied, cyproheptadine which inhibit the functional activities of the level of plasma PRL is increased during the broody dopamine and serotonin and thereby inhibit PRL period (Goldsmith, 1983) . This is consistent with the release to disrupt broodiness in domestic hens t o finding that hypothalamic 5-HT induces PRL release maintain egg production. Again, the results indicate that indirectly by stimulating VIP release which in turn acts VIP is an important PRL releasing neuropeptide i n directly on the anterior pituitary gland (Macnamee and domestic hens. Sharp, 1989a; El Halawani et al., 1990) . The observation that twenty (20%) and thirty five percent chlopromazine and cyproheptadine treated hens respectively did not terminate broodiness may be due to individual variations in the response to the drug treatment, or drug
